P11. Facile aqueous based method to improve mineralization onto PEEK
Saadyah E. Averick, PhD1; Gordon G. Mao, MD2; Andrew Kassick, PhD2; Isaac Swink, MS2
1Allegheny General Hospital, Pittsburgh, PA, US; 2Pittsburgh, PA, US
FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
P12. Comparisons of patterns of upregulation of inflammatory cytokines in herniated nucleus pulposus, disc and nerve root lavagates and in the serum of patients with acute sciatica secondary to lumbar disc herniation undergoing surgery
Paul B. Bishop, MD, PhD, DC1; John Street, MD, PhD2; Jeffrey A. Quon, PhD, DC3; Brian E. Arthur, DC, MSc3; Melissa Nadeau, MD, MHS, FRCSC2; Tamir Ailon, MD, MPH4; Nicolas Dea, MD, MSc, FRCSC2; Charles G. Fisher, MD, FRCSC, MHS5; Brian K. Kwon, MD, PhD, FRCSC2
1Blusson Spine Centre, Vancouver, BC, Canada; 2Blusson Spinal Cord Center, Vancouver, BC, Canada; 3Vancouver, BC, Canada; 4Vancouver Spine Surgery Institute, Vancouver, BC, Canada; 5Vancouver General Hospital, Vancouver, BC, Canada
FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
P14. Comparative effectiveness of expandable versus static lateral lumbar interbody fusion devices: two year clinical and radiographic outcomes
Richard F. Frisch Jr., MD1>; Torrey Shirk, BA2; Charles Gerald T. Ledonio, MD, CCRP2
1Southeastern Spine Institute, Mt Pleasant, SC, US; 2Globus Medical, Audubon, PA, US
FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.